-
1
-
-
0346727461
-
Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis
-
JIMENEZ SA, DERK CT: Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140: 37-50.
-
(2004)
Ann Intern Med
, vol.140
, pp. 37-50
-
-
Jimenez, S.A.1
Derk, C.T.2
-
2
-
-
33745277147
-
Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis
-
BARONI SS, SANTILLO M, BEVILACQUA F et al.: Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis. N Engl J Med 2006; 354: 2667-76.
-
(2006)
N Engl J Med
, vol.354
, pp. 2667-2676
-
-
Baroni, S.S.1
Santillo, M.2
Bevilacqua, F.3
-
3
-
-
0142059804
-
Systemic and cell type-specific gene expression patterns in scleroderma skin
-
WHITFIELD ML, FINLAY DR, MURRAY JI et al.: Systemic and cell type-specific gene expression patterns in scleroderma skin. Proc Natl Acad Sci USA 2003; 100: 12319-24.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 12319-12324
-
-
Whitfield, M.L.1
Finlay, D.R.2
Murray, J.I.3
-
4
-
-
41149106388
-
The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases-2008
-
SHOENFELD Y, BLANK M, ABU-SHAKRA M et al.: The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 2008; 10: 13-9.
-
(2008)
Isr Med Assoc J
, vol.10
, pp. 13-19
-
-
Shoenfeld, Y.1
Blank, M.2
Abu-Shakra, M.3
-
5
-
-
2642511623
-
Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells
-
SATO S, FUJIMOTO M, HASEGAWA M, TAKEHARA K: Altered blood B lymphocyte homeostasis in systemic sclerosis: Expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 2004; 50: 1918-27.
-
(2004)
Arthritis Rheum
, vol.50
, pp. 1918-1927
-
-
Sato, S.1
Fujimoto, M.2
Hasegawa, M.3
Takehara, K.4
-
6
-
-
0024958107
-
Polyclonal B lymphocyte activation in progressive systemic sclerosis
-
FAMULARO G, GIACOMELLI R, ALESSE E et al.: Polyclonal B lymphocyte activation in progressive systemic sclerosis. J Clin Lab Immunol 1989; 29: 59-63.
-
(1989)
J Clin Lab Immunol
, vol.29
, pp. 59-63
-
-
Famularo, G.1
Giacomelli, R.2
Alesse, E.3
-
8
-
-
75749103768
-
Anti-endothelial cell antibodies in systemic sclerosis
-
MIHAI C, TERVAERT JWC: Anti-endothelial cell antibodies in systemic sclerosis. Ann Rheum Dis 2010; 69: 319-24.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 319-324
-
-
Mihai, C.1
Tervaert, J.W.C.2
-
9
-
-
84873647366
-
Pulmonary arterial hypertension: New insights into the optimal role of current and emerging prostacyclin therapies
-
WAXMAN AB, ZAMANIAN RT: Pulmonary arterial hypertension: New insights into the optimal role of current and emerging prostacyclin therapies. Am J Cardiol 2013; 111 (5 Suppl.): 1A-16A.
-
(2013)
Am J Cardiol
, vol.111
, Issue.5
, pp. 1A-16A
-
-
Waxman, A.B.1
Zamanian, R.T.2
-
10
-
-
84921348464
-
Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis
-
BECKER MO, KILL A, KUTSCHE M et al.: Vascular Receptor Autoantibodies in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis. Am J Respir Crit Care Med 2014; 190: 808-17. Available from: http://www.atsjournals.org/doi/abs/10.1164/rccm.201403-0442OC
-
(2014)
Am J Respir Crit Care Med
, vol.190
, pp. 808-817
-
-
Becker, M.O.1
Kill, A.2
Kutsche, M.3
-
11
-
-
0034544489
-
Quantitative genetic variation in CD19 expression correlates with autoimmunity
-
SATO S, HASEGAWA M, FUJIMOTO M, TEDDER TF, TAKEHARA K: Quantitative genetic variation in CD19 expression correlates with autoimmunity. J Immunol 2000; 165: 6635-43.
-
(2000)
J Immunol
, vol.165
, pp. 6635-6643
-
-
Sato, S.1
Hasegawa, M.2
Fujimoto, M.3
Tedder, T.F.4
Takehara, K.5
-
12
-
-
20644457110
-
Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis
-
HASEGAWA M, FUJIMOTO M, TAKEHARA K, SATO S: Pathogenesis of systemic sclerosis: altered B cell function is the key linking systemic autoimmunity and tissue fibrosis. J Dermatol Sci 2005; 39: 1-7.
-
(2005)
J Dermatol Sci
, vol.39
, pp. 1-7
-
-
Hasegawa, M.1
Fujimoto, M.2
Takehara, K.3
Sato, S.4
-
13
-
-
75649124525
-
B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis
-
HASEGAWA M: B lymphocytes: Shedding new light on the pathogenesis of systemic sclerosis. J Dermatol 2010; 37: 3-10.
-
(2010)
J Dermatol
, vol.37
, pp. 3-10
-
-
Hasegawa, M.1
-
14
-
-
0021154318
-
Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations
-
ROUMM AD, WHITESIDE TL, MEDSGER TA, RODNAN GP: Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 1984; 27: 645-53.
-
(1984)
Arthritis Rheum
, vol.27
, pp. 645-653
-
-
Roumm, A.D.1
Whiteside, T.L.2
Medsger, T.A.3
Rodnan, G.P.4
-
15
-
-
84900030650
-
Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease
-
LóPEZ-CACHO JM, GALLARDO S, POSADA M et al.: Association of immunological cell profiles with specific clinical phenotypes of scleroderma disease. Biomed Res Int 2014; 2014: 148293.
-
(2014)
Biomed Res Int
, vol.2014
-
-
López-Cacho, J.M.1
Gallardo, S.2
Posada, M.3
-
16
-
-
84922280087
-
Abnormal B lymphocyte activation and function in systemic sclerosis
-
YOSHIZAKI A, SATO S: Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol 2015; 27: 1-9.
-
(2015)
Ann Dermatol
, vol.27
, pp. 1-9
-
-
Yoshizaki, A.1
Sato, S.2
-
17
-
-
85027911427
-
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
-
JORDAN S, DISTLER JHW, MAURER B et al.: Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Ann Rheum Dis (Internet). 2014;1-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24442885
-
(2014)
Ann Rheum Dis
, pp. 1-7
-
-
Jordan, S.1
Distler, J.H.W.2
Maurer, B.3
-
18
-
-
59649109772
-
B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis
-
LAFYATIS R, KISSIN E, YORK M et al.: B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2009; 60: 578-83.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 578-583
-
-
Lafyatis, R.1
Kissin, E.2
York, M.3
-
19
-
-
84863300540
-
Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab
-
YOO WH: Successful treatment of steroid and cyclophosphamide-resistant diffuse scleroderma-associated interstitial lung disease with rituximab. Rheumatol Int 2012; 32: 795-8.
-
(2012)
Rheumatol Int
, vol.32
, pp. 795-798
-
-
Yoo, W.H.1
-
20
-
-
84926341813
-
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis
-
BOSELLO SL, DE LUCA G, RUCCO M et al.: Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis. Semin Arthritis Rheum 2015; 44: 428-36.
-
(2015)
Semin Arthritis Rheum
, vol.44
, pp. 428-436
-
-
Bosello, S.L.1
De Luca, G.2
Rucco, M.3
-
21
-
-
33748788266
-
B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis
-
HASEGAWA M, HAMAGUCHI Y, YANABA K et al.: B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006; 169: 954-66.
-
(2006)
Am J Pathol
, vol.169
, pp. 954-966
-
-
Hasegawa, M.1
Hamaguchi, Y.2
Yanaba, K.3
-
22
-
-
77950443096
-
Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study
-
DAOUSSIS D, LIOSSIS SNC, TSAMANDAS AC et al.: Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study. Rheumatology 2010; 49: 271-80.
-
(2010)
Rheumatology
, vol.49
, pp. 271-280
-
-
Daoussis, D.1
Liossis, S.N.C.2
Tsamandas, A.C.3
-
23
-
-
16544364829
-
The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system
-
TEDDER TF, POE JC, FUJIMOTO M, HAAS KM, SATO S: The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. Curr Dir Autoimmun 2005; 8: 55-90.
-
(2005)
Curr Dir Autoimmun
, vol.8
, pp. 55-90
-
-
Tedder, T.F.1
Poe, J.C.2
Fujimoto, M.3
Haas, K.M.4
Sato, S.5
-
25
-
-
0034669990
-
Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus
-
ODENDAHL M, JACOBI A, HANSEN A et al.: Disturbed peripheral B lymphocyte homeostasis in systemic lupus erythematosus. J Immunol 2000; 165: 5970-9.
-
(2000)
J Immunol
, vol.165
, pp. 5970-5979
-
-
Odendahl, M.1
Jacobi, A.2
Hansen, A.3
-
26
-
-
84870980098
-
IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAPbut not UNC-93B-deficient patients
-
WELLER S, BONNET M, DELAGREVERIE H et al.: IgM+IgD+CD27+ B cells are markedly reduced in IRAK-4-, MyD88-, and TIRAPbut not UNC-93B-deficient patients. Blood 2012; 120: 4992-5001.
-
(2012)
Blood
, vol.120
, pp. 4992-5001
-
-
Weller, S.1
Bonnet, M.2
Delagreverie, H.3
-
27
-
-
0036676086
-
Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome
-
HANSEN A, ODENDAHL M, REITER K et al.: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum 2002; 46: 2160-71.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 2160-2171
-
-
Hansen, A.1
Odendahl, M.2
Reiter, K.3
-
28
-
-
0032528846
-
Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome
-
AGEMATSU K, NAGUMO H, SHINOZAKI K et al.: Absence of IgD-CD27+ memory B cell population in X-linked hyper-IgM syndrome. J Clin Invest 1998; 102: 853-60.
-
(1998)
J Clin Invest
, vol.102
, pp. 853-860
-
-
Agematsu, K.1
Nagumo, H.2
Shinozaki, K.3
-
29
-
-
0036493366
-
Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease
-
WARNATZ K, DENZ A, DRA R et al.: Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 2002; 99: 1544-52.
-
(2002)
Blood
, vol.99
, pp. 1544-1552
-
-
Warnatz, K.1
Denz, A.2
Dra, R.3
-
30
-
-
39649097890
-
Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks
-
ANOLIK JH, RAVIKUMAR R, BARNARD J et al.: Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks. J Immunol 2008; 180: 688-92.
-
(2008)
J Immunol
, vol.180
, pp. 688-692
-
-
Anolik, J.H.1
Ravikumar, R.2
Barnard, J.3
-
31
-
-
84907385240
-
Primary Sjögren's Syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory cells
-
ROBERTS MEP, KAMINSKI D, JENKS SA et al.: Primary Sjögren's Syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory cells. Arthritis Rheumatol 2014; 66: 2558-69.
-
(2014)
Arthritis Rheumatol
, vol.66
, pp. 2558-2569
-
-
Roberts, M.E.P.1
Kaminski, D.2
Jenks, S.A.3
-
32
-
-
34248140178
-
A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus
-
WEI C, ANOLIK J, CAPPIONE A et al.: A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007; 178: 6624-33.
-
(2007)
J Immunol
, vol.178
, pp. 6624-6633
-
-
Wei, C.1
Anolik, J.2
Cappione, A.3
-
33
-
-
45349091226
-
Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95
-
JACOBI AM, REITER K, MacKAY M et al.: Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: Delineation by expression of CD27, IgD, and CD95. Arthritis Rheum 2008; 58: 1762-73.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 1762-1773
-
-
Jacobi, A.M.1
Reiter, K.2
Mackay, M.3
-
34
-
-
84878571051
-
Derailed B cell homeostasis in patients with mixed connective tissue disease
-
HAJAS A, BARATH S, SZODORAY P et al.: Derailed B cell homeostasis in patients with mixed connective tissue disease. Hum Immunol 2013; 74: 833-41.
-
(2013)
Hum Immunol
, vol.74
, pp. 833-841
-
-
Hajas, A.1
Barath, S.2
Szodoray, P.3
-
35
-
-
84866171442
-
The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral Blood
-
WU Y-CB, KIPLING D, DUNN-WALTERS DK: The Relationship between CD27 Negative and Positive B Cell Populations in Human Peripheral Blood. Front Immunol 2011; 2: 81.
-
(2011)
Front Immunol
, vol.2
, pp. 81
-
-
Wu, Y.-C.B.1
Kipling, D.2
Dunn-Walters, D.K.3
-
36
-
-
0023854176
-
Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
-
LEROY CE, BLACK C, FLEISCHMAJER R et al.: Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5.
-
(1988)
J Rheumatol
, vol.15
, pp. 202-205
-
-
Leroy, C.E.1
Black, C.2
Fleischmajer, R.3
-
37
-
-
84886777196
-
2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative
-
Van Den HOOGEN F, KHANNA D, FRANSEN J et al.: 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum 2013; 65: 2737-47.
-
(2013)
Arthritis Rheum
, vol.65
, pp. 2737-2747
-
-
Van Den Hoogen, F.1
Khanna, D.2
Fransen, J.3
-
38
-
-
77953484773
-
Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis
-
MINIER T, NAGY Z, BáLINT Z et al.: Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis. Rheumatology (Oxford) 2010; 49: 1133-45.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1133-1145
-
-
Minier, T.1
Nagy, Z.2
Bálint, Z.3
-
39
-
-
37749017657
-
Survival and causes of death in 366 Hungarian patients with systemic sclerosis
-
CZIRJáK L, KUMáNOVICS G, VARJú C et al.: Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 59-63.
-
(2008)
Ann Rheum Dis
, vol.67
, pp. 59-63
-
-
Czirják, L.1
Kumánovics, G.2
Varjú, C.3
-
40
-
-
0042386341
-
European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score
-
VALENTINI G, D'ANGELO S, DELLA ROSSA A, BENCIVELLI W, BOMBARDIERI S: European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. IV. Assessment of skin thickening by modified Rodnan skin score. Ann Rheum Dis 2003; 62: 904-5.
-
(2003)
Ann Rheum Dis
, vol.62
, pp. 904-905
-
-
Valentini, G.1
D'angelo, S.2
Della Rossa, A.3
Bencivelli, W.4
Bombardieri, S.5
-
41
-
-
84934288965
-
B Cells in Autoimmune Diseases
-
HAMPE CS: B Cells in Autoimmune Diseases. Scientifica (Cairo) 2012; 2012: 1-18.
-
(2012)
Scientifica (Cairo)
, vol.2012
, pp. 1-18
-
-
Hampe, C.S.1
-
42
-
-
2942537697
-
Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
-
EDWARDS JCW, SZCZEPANSKI L, SZECHINSKI J et al.: Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N Engl J Med 2004; 350: 2572-81.
-
(2004)
N Engl J Med
, vol.350
, pp. 2572-2581
-
-
Edwards, J.C.W.1
Szczepanski, L.2
Szechinski, J.3
-
43
-
-
84871031165
-
Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent?
-
Van ZELM MC: Human CD27+IgM+IgD+ B cells: T-cell or TLR-dependent? Blood 2012; 120: 4905-6.
-
(2012)
Blood
, vol.120
, pp. 4905-4906
-
-
Van Zelm, M.C.1
-
44
-
-
77952817885
-
Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients
-
RODRíGUEZ-BAYONA B, RAMOS-AMAYA A, PéREZ-VENEGAS JJ, RODRíGUEZ C, BRIEVA JA: Decreased frequency and activated phenotype of blood CD27 IgD IgM B lymphocytes is a permanent abnormality in systemic lupus erythematosus patients. Arthritis Res Ther 2010; 12: R108.
-
(2010)
Arthritis Res Ther
, vol.12
, pp. R108
-
-
Rodríguez-Bayona, B.1
Ramos-Amaya, A.2
Pérez-Venegas, J.J.3
Rodríguez, C.4
Brieva, J.A.5
-
45
-
-
34848912304
-
Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy
-
ANOLIK JH, BARNARD J, OWEN T et al.: Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy. Arthritis Rheum 2007; 56: 3044-56.
-
(2007)
Arthritis Rheum
, vol.56
, pp. 3044-3056
-
-
Anolik, J.H.1
Barnard, J.2
Owen, T.3
-
46
-
-
33748509736
-
A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation
-
FECTEAU JF, CôTé G, NéRON S: A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006; 177: 3728-36.
-
(2006)
J Immunol
, vol.177
, pp. 3728-3736
-
-
Fecteau, J.F.1
Côté, G.2
Néron, S.3
-
47
-
-
0031754828
-
Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
-
PETER ME, KRAMMER PH: Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis. Curr Opin Immunol 1998; 10: 545-51.
-
(1998)
Curr Opin Immunol
, vol.10
, pp. 545-551
-
-
Peter, M.E.1
Krammer, P.H.2
-
48
-
-
34247536682
-
The CD95 Receptor: Apoptosis Revisited
-
PETER ME, BUDD RC, DESBARATS J et al.: The CD95 Receptor: Apoptosis Revisited. Cell 2007; 129: 447-50.
-
(2007)
Cell
, vol.129
, pp. 447-450
-
-
Peter, M.E.1
Budd, R.C.2
Desbarats, J.3
-
49
-
-
5044228305
-
Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation
-
MA Y, LIU H, TU-RAPP H et al.: Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 2004; 5: 380-7.
-
(2004)
Nat Immunol
, vol.5
, pp. 380-387
-
-
Ma, Y.1
Liu, H.2
Tu-Rapp, H.3
-
50
-
-
77953568668
-
Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of proinflammatory HMGB1 from macrophages
-
WANG F, LU Z, HAWKES M, YANG H, KAIN KC, LILES WC: Fas (CD95) induces rapid, TLR4/IRAK4-dependent release of proinflammatory HMGB1 from macrophages. J Inflamm 2010; 7: 30.
-
(2010)
J Inflamm
, vol.7
, pp. 30
-
-
Wang, F.1
Lu, Z.2
Hawkes, M.3
Yang, H.4
Kain, K.C.5
Liles, W.C.6
|